{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T16:35:27Z","timestamp":1785256527308,"version":"3.55.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T00:00:00Z","timestamp":1533686400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003645","name":"National Cancer Center","doi-asserted-by":"publisher","award":["NCC-1610200"],"award-info":[{"award-number":["NCC-1610200"]}],"id":[{"id":"10.13039\/501100003645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4700-3","type":"journal-article","created":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T07:54:58Z","timestamp":1533714898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Second primary cancer after primary peritoneal, epithelial ovarian, and fallopian tubal cancer: a retrospective study"],"prefix":"10.1186","volume":"18","author":[{"given":"Myong Cheol","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Joo","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwon","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahereh","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong Woo","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Bristow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,8]]},"reference":[{"issue":"1","key":"4700_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"4700_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3802\/jgo.2013.24.4.298","volume":"24","author":"MC Lim","year":"2013","unstructured":"Lim MC, Moon E-K, Shin A, Jung K-W, Won Y-J, Seo SS, Kang S, Kim J-W, Kim J-Y, Park S-Y. Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010. J Gynecol Oncol. 2013;24(4):298\u2013302.","journal-title":"J Gynecol Oncol"},{"issue":"2","key":"4700_CR3","doi-asserted-by":"publisher","first-page":"306","DOI":"10.4143\/crt.2017.130","volume":"49","author":"KW Jung","year":"2017","unstructured":"Jung KW, Won YJ, Oh CM, Kong HJ, Lee DH, Lee KH. Prediction of Cancer incidence and mortality in Korea, 2017. Cancer Res Treat. 2017;49(2):306\u201312.","journal-title":"Cancer Res Treat"},{"issue":"Suppl 2","key":"4700_CR4","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.1016\/j.ijgo.2015.06.007","volume":"131","author":"JS Berek","year":"2015","unstructured":"Berek JS, Crum C, Friedlander M. Cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2015;131(Suppl 2):S111\u201322.","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"4700_CR5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1245\/s10434-015-4613-1","volume":"23","author":"HS Bae","year":"2016","unstructured":"Bae HS, Lim MC, Lee JS, Lee Y, Nam BH, Seo SS, Kang S, Chung SH, Kim JY, Park SY. Postoperative lower extremity edema in patients with primary endometrial Cancer. Ann Surg Oncol. 2016;23(1):186\u201395.","journal-title":"Ann Surg Oncol"},{"key":"4700_CR6","unstructured":"SEER*Explorer: An interactive website for SEER cancer statistics [Internet]. Surveillance Research Program, National Cancer Institute. [cited June 17, 2018]. Available from [\n                    https:\/\/seer.cancer.gov\/explorer\/\n                    \n                  ]."},{"issue":"11","key":"4700_CR7","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00432-009-0607-3","volume":"135","author":"MC Lim","year":"2009","unstructured":"Lim MC, Kang S, Seo SS, Kong SY, Lee BY, Lee SK, Park SY. BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients. J Cancer Res Clin Oncol. 2009;135(11):1593\u20139.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"4700_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.critrevonc.2008.06.003","volume":"69","author":"A Russo","year":"2009","unstructured":"Russo A, Calo V, Bruno L, Rizzo S, Bazan V, Di Fede G. Hereditary ovarian cancer. Crit Rev Oncol Hematol. 2009;69(1):28\u201344.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"12","key":"4700_CR9","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1093\/jjco\/hyq144","volume":"40","author":"MC Lim","year":"2010","unstructured":"Lim MC, Seo SS, Kang S, Seong MW, Lee BY, Park SY. Hereditary non-polyposis colorectal cancer\/lynch syndrome in Korean patients with endometrial cancer. Jpn J Clin Oncol. 2010;40(12):1121\u20137.","journal-title":"Jpn J Clin Oncol"},{"issue":"13","key":"4700_CR10","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1001\/jama.2014.5985","volume":"313","author":"TR Rebbeck","year":"2015","unstructured":"Rebbeck TR, Mitra N, Wan F, Sinilnikova OM, Healey S, McGuffog L, Mazoyer S, Chenevix-Trench G, Easton DF, Antoniou AC, et al. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA. 2015;313(13):1347\u201361.","journal-title":"JAMA"},{"issue":"2 Pt 1","key":"4700_CR11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/AOG.0b013e31825f3576","volume":"120","author":"KA Schrader","year":"2012","unstructured":"Schrader KA, Hurlburt J, Kalloger SE, Hansford S, Young S, Huntsman DG, Gilks CB, McAlpine JN. Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy. Obstet Gynecol. 2012;120(2 Pt 1):235\u201340.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"4700_CR12","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.3802\/jgo.2017.28.e51","volume":"28","author":"MC Lim","year":"2017","unstructured":"Lim MC, Randall LM. Role and clinical application of next-generation sequencing (NGS) for ovarian cancer. J Gynecol Oncol. 2017;28(4):e51.","journal-title":"J Gynecol Oncol"},{"issue":"3","key":"4700_CR13","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ygyno.2011.07.097","volume":"123","author":"A Vay","year":"2011","unstructured":"Vay A, Kumar S, Seward S, Semaan A, Schiffer CA, Munkarah AR, Morris RT. Therapy-related myeloid leukemia after treatment for epithelial ovarian carcinoma: an epidemiological analysis. Gynecol Oncol. 2011;123(3):456\u201360.","journal-title":"Gynecol Oncol"},{"issue":"38","key":"4700_CR14","doi-asserted-by":"publisher","first-page":"e1626","DOI":"10.1097\/MD.0000000000001626","volume":"94","author":"YP Hung","year":"2015","unstructured":"Hung YP, Liu CJ, Hu YW, Chen MH, Li CP, Yeh CM, Chiou TJ, Chen TJ, Yang MH, Chao Y. Secondary primary malignancy risk in patients with ovarian Cancer in Taiwan: a Nationwide population-based study. Medicine (Baltimore). 2015;94(38):e1626.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"4700_CR15","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1001\/jama.2012.20","volume":"307","author":"KL Bolton","year":"2012","unstructured":"Bolton KL, Chenevix-Trench G, Goh C, Sadetzki S, Ramus SJ, Karlan BY, Lambrechts D, Despierre E, Barrowdale D, McGuffog L, et al. Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA. 2012;307(4):382\u201390.","journal-title":"JAMA"},{"issue":"26","key":"4700_CR16","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","volume":"372","author":"DT Le","year":"2015","unstructured":"Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, et al. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015;372(26):2509\u201320.","journal-title":"N Engl J Med"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4700-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4700-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4700-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T13:42:53Z","timestamp":1569159773000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4700-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,8]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4700"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4700-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,8]]},"assertion":[{"value":"2 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was reviewed and approved by the Ethics committee of National Cancer Center on 14 July 2017. The approval number is No. NCC2017\u20130167. We requested and obtained the cancer registration data (de-identified) used in this study from the Korea Central Cancer Registry (KCCR).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"800"}}